ALKEMAlkem Laboratories Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹5,653.50
▲ 1.63%Decent
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)67,596.10
P/E29.37
P/B4.89
PEG—
ROE %17.56
ROCE %16.50
Debt / Equity0.14
EPS192.48
Revenue Growth %14.60
Profit Growth %-22.70
Dividend Yield %0.90
Promoter Holding %62.44
FII Holding %26.34
DII Holding %—
Beta0.27
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Supertrend Buy | LONG | 59% | ₹5,653.50 | ₹5,345.72 | ₹6,269.06 | 2.00 |
HOLDConviction 71%
The picture
- • ROE: 17.6%
- • ROCE: 16.5%
- • Debt/Equity: 0.14
- • RSI: 58
- • MACD: bullish
- • Price vs EMA21: above
- • Supertrend Buy signal (setup quality 59%)
Bull case
- • ROE: 17.6%
- • ROCE: 16.5%
- • Debt/Equity: 0.14
- • RSI: 58
Bear case
- • Profit growth: -22.7% YoY
- • Golden cross setup: SMA50 below SMA200
- • Volume: 0.6x 20-day average
- • 3-month return: +0.5%
Key risks
- • Profit growth: -22.7% YoY
- • Golden cross setup: SMA50 below SMA200
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹5,653.50
Stop Loss
₹5,350.68
risk 5.4%
Target 1 (1.5R)
₹6,107.73
+8.0%
Target 2 (3R)
₹6,561.96
+16.1%
Support (20d)
₹5,394.00
Resistance (52w)
₹5,886.05
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹302.82/share
ATR (volatility)
₹121.13
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹121.13). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
66
Technical
69
Momentum
56
Risk (safety)
85